ADR,SEQ,ROUTE,MULTICONST,NONSERIOUS_SERIOUS_FATAL_NSF
1,1,ORAL USE,N,N
2,1,ORAL USE,N,S
3,1,ORAL USE,N,N
4,1,ORAL USE,N,S
5,1,ORAL USE,N,S
